DARMSTADT, Germany, Sept. 13, 2017 /PRNewswire/ — Sizes range from 50-liter to 2,000-liter manufacturing scale Industry-leading design offers flexibility, scalability and ease-of-use Merck, a leading Continue Reading
MTC
Fiasp(R) Significantly Improved Overall Blood Sugar Control in Type 1 Diabetes Long-term
LISBON, Portugal, Sept. 12, 2017 /PRNewswire/ — Fiasp® (fast-acting insulin aspart), the only approved, new-generation, ultra-fast acting[1]–[3] mealtime insulin, improved overall blood sugar (HbA1c) and Continue Reading
Unleashing the Power of the Latest Pharmaceutical Research for Simplified Global Healthcare Solutions through Conference Series Pharma meetings
Conference Series has scheduled 300 more Pharma meetings for 2018 in 30+ countries LONDON, and SINGAPORE, Sept. 12, 2017 /PRNewswire/ — Associated with over 1000 scientific societies and Continue Reading
Merck Set to Join Forces with Project Data Sphere to Pioneer Global Oncology Big Data Alliance
DARMSTADT, Germany, Sept. 11, 2017 /PRNewswire/ — Not intended for U.K./U.S. based media Big data platform to help accelerate innovative discovery, development and delivery of Continue Reading
Galderma: Combined Use of Rosacea Therapies Ivermectin 1% Cream and Brimonidine 0.33% Gel Evaluated in MOSAIC Study
LAUSANNE, Switzerland, Sept. 11, 2017 /PRNewswire/ — Today, the results of a study evaluating the combined use of topical rosacea treatments ivermectin 1% cream and brimonidine Continue Reading
Frost & Sullivan Applauds STANLEY Healthcare’s Design Innovation and Leadership in Addressing the Changing Needs of the Senior Living Industry
STANLEY Healthcare’s user-friendly, unobtrusive innovations address challenges in the market, making senior living communities tech savvy and future ready for implementing efficient senior care SANTA Continue Reading
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for Its Proprietary DETOUR System for Percutaneous Bypass
Novel technology enables a new, minimally invasive treatment for patients suffering from extremely long peripheral artery blockages LONDON, Aug. 31, 2017 /PRNewswire/ — Frost & Sullivan Continue Reading
Merck Collaborates with Angiex to Speed Clinical Readiness of New Cancer Therapy
– Project is first for Merck’s Massachusetts BioReliance® End-to-End Solutions center – Collaboration gives Angiex access to Merck’s process development tools and technologies DARMSTADT, Germany, Continue Reading
Ganeden Brings Probiotic Exhibit and Expertise to Fi Asia
Global leader will discuss probiotic formulation trends, science updates and product launches CLEVELAND, Aug. 29, 2017 /PRNewswire/ — As probiotic fortification continues to gain momentum around Continue Reading
Merck to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities
— Boosts Merck’s single-use chromatography portfolio — Accelerates Merck’s mAb and vaccine manufacturing offering DARMSTADT, Germany, Aug. 28, 2017 /PRNewswire/ — Merck, a leading science and Continue Reading